Clinical Trial Update: Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor [NA]

View source ↗

Summary

This clinical trial status update indicates a recruiting study in cystic fibrosis patients treated with the triple CFTR modulator elexacaftor/tezacaftor/ivacaft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)

Snippet

Sponsor: University Hospital, Lille | Conditions: Cystic Fibrosis (CF), Mucoviscidosis | NA | Status: RECRUITING